Faucett Neill B
Known title: DirectorCIK: 0001994122
Faucett Neill B's purchase track record
Faucett Neill B has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/23/2025 | SDHC | $122K | +19.7% | +1.0% | +13.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SDHC | ▲ Buy | Grant | 2,466 | $25K | 10/1/2026 | View on chart |
| SDHC | ▲ Buy | Grant | 1,612 | $25K | 7/1/2026 | View on chart |
| SDHC | ▲ Buy | Grant | 10,008 | $0 | 6/4/2026 | View on chart |
| SDHC | ▲ Buy | Grant | 1,745 | $25K | 4/8/2026 | View on chart |
| SDHC | ▲ Buy | Grant | 6,543 | $0 | 6/5/2025 | View on chart |
| SDHC | ▲ Buy | Open Market | 7,000 | $122K | 5/23/2025 | View on chart |
| SDHC | ▲ Buy | Grant | 3,934 | $0 | 6/4/2024 | View on chart |
| SDHC | ▲ Buy | Grant | 3,571 | $0 | 1/16/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
RBC lowers price target for Smith Douglas Homes to $10
RBC Capital kept its sector‑perform rating on Smith Douglas Homes but reduced its price target to $10. The new target is below the three‑analyst average of $13 and close to the stock’s recent support around $9.80. This adjustment reflects a more cautious outlook amid the current valuation. The change comes as the stock sits near the middle of its 52‑week range with a neutral RSI.
RBC lowers price target for Smith Douglas Homes to $10. RBC Capital kept its sector‑perform rating on Smith Douglas Homes but reduced its price target to $10. The new target is below the three‑analyst average of $13 and close to the stock’s recent support around $9.80. This adjustment reflects a more cautious outlook amid the current valuation. The change comes as the stock sits near the middle of its 52‑week range with a neutral RSI.